Pharma Industry News Johnson & Johnson’s stay-out-of-jail marketing for schizophrenia blockbuster Invega Sustenna raises eyebrows 8 years ago
Pharma Industry News Pharma unleashes lobbying power to fight surprising—and costly—changes to Medicare Part D 8 years ago
Pharma Industry News Celgene completes first phase of manufacturing facility for CAR-T effort with Bluebird Bio 8 years ago
Pharma Industry News Bristol-Myers Squibb and Nektar Therapeutics announce global development & commercialization collaboration for Nektar’s CD122-biased agonist, NKTR-214 8 years ago